Skip to main navigation menu Skip to main content Skip to site footer

Validation of the prognostic scale Pulmonary Embolism Severity Index (PESI) in patients diagnosed with pulmonary embolism

Validación de la escala pronóstica PESI en pacientes con diagnóstico de tromboembolia pulmonar




Section
Research article

How to Cite
Validation of the prognostic scale Pulmonary Embolism Severity Index (PESI) in patients diagnosed with pulmonary embolism.
rev. colomb. neumol. [Internet]. 2016 Oct. 25 [cited 2024 Nov. 22];25(4). Disponible en: https://doi.org/10.30789/rcneumologia.v25.n4.2013.96

Dimensions
PlumX
license

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Darío Londoño Trujillo, MD., MSc.
    Olga Milena García Morales, MD.

      Darío Londoño Trujillo, MD., MSc.,

      Internista, Neumólogo. Unidad de Neumología, Hospital Universitario San Ignacio, Facultad de Medicina, Pontificia Universidad Javeriana. Bogotá, Colombia.


      Olga Milena García Morales, MD.,

      Internista. Departamento de Medicina Interna, Hospital Universitario San Ignacio. Facultad de Medicina, Pontificia Universidad Javeriana. Bogotá. Colombia.


      Background: Pulmonary embolism (PE) is a disease with significant impact on public health; mortality rates are between 7-11% depending on the extent of the pathology and the clinical condition of the patient prior to the event, is important for the clinician to establish the prognosis in the short and medium term for taking behaviors with patient.

      Objectives: To validate PESI scale in patients with a diagnosis of TEV, as forecast tool to guide the conduct of clinical emergency and general wards and assess the prognostic power of the scale to determine adverse outcomes included 30-day mortality according to category in which the patient is classified.

      Materials and methods: Retrospective cohort of adults with diagnosis of TEV, including through the review of clinical records and Angiotomografias in at University Hospital. Operational characteristics of the pronostic scale PESI in the population described were evaluated.

      Results: A higher mortality rate, right ventricular dysfunction, inotropy requirement, requirement for ICU care, use of hospital and ambulatory oxygen in the high-risk group (groups III, IV and V) compared to low-risk, was documented with statistically significant differences.

      Conclusions: According to our findings, the PESI scale is similar to that reported in other cohorts behavior, so it can be considered applicable in our environment to determine which patients are low risk and possibly consider an outpatient management.


      Article visits 1021 | PDF visits 14981


      Downloads

      Download data is not yet available.
      1. Silverstein MD, Heit JA. Trends in the incidence of deep vein thrombosis and pulmonary embolism. Ach Intern Med. 1998;158(6):585-93.
      2. Anderson Jr FA, Wheeler HB, Goldberg RJ, et al. A population based perspective of the hospital incidence and case fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT study. Arch Intern Med. 1991;151(5):933-8.
      3. Torbicki A, Perrier A, Konstantinides S. Guías de práctica clínica de la Sociedad Europea de Cardiología. Guías de práctica clínica sobre diagnóstico y manejo del tromboembolismo pulmonar agudo. Rev Esp Cardiol. 2008;61(12):1330.e1-330.e52.
      4. Jaff M, McMutry S. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic hypertension: AHA. Circulation. 2011; 123.
      5. Aujesky D, Jimenez D, Mor MK, et al. Weekend versus weekday admission and mortality after acute pulmonary embolism. Circulation. 2009;119(7):962-8.
      6. Konstantinides S. Pulmonary embolism: impact of right ventricular dysfuntion. Curr Opin Cardiol. 2005;20(6):496-501.
      7. Wicki J, Perrier A, Perneger TV, et al. Predicting adverse outcomes in patients with acute pulmonary embolism: a risk score. Thromb Haemost. 2000;84(4):548-552.
      8. Aujesky D, Obrosky S, Stone R. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005; 172:1041-1046
      9. Jimenez D, Yusen RD, Otero R, Uresandi F, Nauffal D, Laserna E. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Chest 2007; 132 (1): 24-30.
      10. O’Flaherty M, Gandara E. A simple prediction rule identified patients with pulmonary embolism at low risk of short term death. Ev Based Med. 2006;11:121.
      11. Aujesky D, Roy P, Petit C. Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J. 2006; 27:476-481.
      12. Nendaz MR, Bandelier P, Aujesky D. Validation of a risk score identifying patients with acute pulmonary embolism, who are at low risk of clinical adverse outcome. Thromb Haemost. 2004;91:1232-1236.
      13. Aujesky D, Hughes R, Jimenez D. Short-term prognosis of pulmonary embolism. J Thromb Haemost.2009;7(Suppl.1):318-21.
      Sistema OJS 3.4.0.7 - Metabiblioteca |